Congenital Thrombotic Thrombocytopenic Purpura
📧 Sign up to get email alerts when something new happens for Congenital Thrombotic Thrombocytopenic Purpura.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access Program
A clinical trial update describing a study to learn more about treating congenital thrombotic thrombocytopenic purpura (cTTP) with recombina…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma
Clinical trial update for a study of Adzynma in children and adults with congenital thrombotic thrombocytopenic purpura; the trial is not ye…
-
CLINICAL_TRIALS approval · 2025-02-24Clinical Trial Update: Expanded Access Program of TAK-755 for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
Takeda's TAK-755 expanded access program for congenital thrombotic thrombocytopenic purpura has been approved for marketing, enabling broade…
-
CLINICAL_TRIALS withdrawal · 2012-12-21Clinical Trial Update: Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura [Phase 4]
The Phase 4 trial of prophylactic plasma infusion therapy for congenital thrombotic thrombocytopenic purpura has been withdrawn.